Announcements Trials

Browse Landscape

Phase

Phase 2 34 Phase 1 22 Phase 1/2 21 Phase NA 7 Phase 3 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Completed 24 Unknown 9 Terminated 5 Recruiting 4 Not yet recruiting 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16 Breast 12 Tumor-Agnostic 5 Thoracic 5 Lymphoid 5 Genitourinary 4 CNS 4 Plasma cell 3 Other hematologic neoplasm 3 Head & Neck 3 Dermatologic 3 Classical hematology 3 Gynecologic 2 Other 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Myeloid × Clear all

NCT01605981 2017-04-20

MACS1881

Novartis

Phase 4 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡